One of the 21st century’s greatest economic miracles is how Taiwan – a small, island nation of ambiguous political status – managed to scale the value chain and transform itself into a regional industrial and technological powerhouse.
While this remarkable economic growth was largely due to a perspicacious early embrace of the semi-conductor industry on Taiwan, Taiwanese healthcare and life sciences — especially biotechnology — is fast gaining in importance and acquiring a global reputation. President Tsai Ing-wen herself has a background in biosciences, and many of the companies and institutions featured in the report are positioned at the vanguard of new innovations and technology in biotech.
Key themes featured in this report include Taiwan’s new, life science-focused, economic model; the ways in which Taiwanese biotechs are leveraging the island’s tradition of technological excellence to drive them to new heights; the spate of recent, high-profile IPOs for Taiwanese start-ups and university spin-offs; and new efforts to create innovation and knowledge-sharing clusters throughout the island.
Also featured in the report is a special section, “Five biotechs to watch,” which shines a spotlight on five of Taiwan’s most cutting-edge and innovative biotechnology companies.
For companies, investors, policymakers, and stakeholders wanting to gain insight into how Taiwan has achieved such success in healthcare and life sciences in a relatively short period of time, as well as how the country stands to step up a gear and take its place at the top table of global bioscience, this report is a must-have.